Insider · CIK 0001780209
Alan Ezekowitz
Files at FULC (Fulcrum Therapeutics, Inc.), OGN (Organon & Co.), SEPN (Septerna, Inc.). First filing Mar 6, 2025, latest Mar 10, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SEPN: Septerna, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Septerna, Inc. | $92k 13,319 shares | +13% | - | |
| 51Moderate | Septerna, Inc. | $516k 86,681 shares | +498% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Jun 30, 2025 |
| Jun 17, 2025 | SEPN Septerna, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,623 | $0.00 | $0 | 16,623 | Jun 20, 2025 |
| Jun 13, 2025 | OGN Organon & Co. | AGrant or award Phantom Stockderivative | +23,904 | $10.04 | $240k | 62,703 | Jun 16, 2025 |
| Mar 7, 2025 | SEPN Septerna, Inc. | POpen-market purchase Common Stock | +13,319 | $6.93 | $92k | 117,420 | Mar 10, 2025 |
| Mar 4, 2025 | SEPN Septerna, Inc. | POpen-market purchase Common Stock | +7,491 | $6.35 | $48k | 24,911 | Mar 6, 2025 |
| Mar 5, 2025 | SEPN Septerna, Inc. | POpen-market purchase Common Stock | +37,835 | $5.82 | $220k | 62,746 | Mar 6, 2025 |
| Mar 6, 2025 | SEPN Septerna, Inc. | POpen-market purchase Common Stock | +41,355 | $6.00 | $248k | 104,101 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.